Literature DB >> 26362070

Eight cases of salvage pulmonary resection for residual disease or isolated local recurrence detected after definitive chemoradiotherapy for N2 Stage-IIIA lung cancer.

Shigeki Sawada1, Hiroshi Suehisa2, Tsuyoshi Ueno2, Motohiro Yamashita2.   

Abstract

BACKGROUND/
OBJECTIVE: The concept of salvage pulmonary resection after definitive chemoradiotherapy (dCRT) is not yet commonly accepted in lung cancer treatment. We report our experience of eight patients in whom we performed salvage pulmonary resection for residual disease or isolated locoregional recurrence detected after dCRT.
METHODS: Between 2005 and 2014, we performed salvage pulmonary resection for eight patients with N2 Stage-IIIA non-small cell lung cancer. The patients had initially received dCRT (radiation ≤ 60 Gy), but eventually underwent pulmonary resection with curative intent for residual disease or isolated locoregional recurrence. The postoperative complications, incidence of recurrence, and survival parameters were evaluated.
RESULTS: Salvage pulmonary resection was performed in four patients with residual disease and four patients with locoregional recurrence. Complete resection was successfully performed in all eight patients. Postoperative complications were observed in three patients, however, there were no postoperative mortalities. One patient developed local recurrence in a mediastinal lymph node and two patients died. Of the two fatalities, one was related to lung cancer. The estimated 5-year survival rate of the eight patients was 75.0%.
CONCLUSION: We report our experience of salvage pulmonary resection performed for residual disease or isolated locoregional recurrence diagnosed after dCRT in eight patients with locally advanced lung cancer. Although the postoperative complication rate was high, the survival data were favorable. A larger study is needed to confirm the safety and feasibility of salvage pulmonary resection after dCRT.
Copyright © 2017. Published by Elsevier Taiwan.

Entities:  

Keywords:  chemotherapy; lung cancer; outcomes; radiation; salvage resection; surgery

Mesh:

Year:  2015        PMID: 26362070     DOI: 10.1016/j.asjsur.2015.05.006

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  2 in total

1.  Salvage thoracic surgery in patients with lung cancer: potential indications and benefits.

Authors:  Erkan Kaba; Mehmet Oguzhan Ozyurtkan; Kemal Ayalp; Tugba Cosgun; Mazen Rasmi Alomari; Alper Toker
Journal:  J Cardiothorac Surg       Date:  2018-01-22       Impact factor: 1.637

Review 2.  Salvage surgery for recurrent or persistent tumour after radical (chemo)radiotherapy for locally advanced non-small cell lung cancer: a systematic review.

Authors:  Chris Dickhoff; Rene H J Otten; Martijn W Heymans; Max Dahele
Journal:  Ther Adv Med Oncol       Date:  2018-10-05       Impact factor: 8.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.